219 related articles for article (PubMed ID: 22843279)
1. Markedly upregulated serum interleukin-12 as a novel biomarker in POEMS syndrome.
Kanai K; Sawai S; Sogawa K; Mori M; Misawa S; Shibuya K; Isose S; Fujimaki Y; Noto Y; Sekiguchi Y; Nasu S; Nakaseko C; Takano S; Yoshitomi H; Miyazaki M; Nomura F; Kuwabara S
Neurology; 2012 Aug; 79(6):575-82. PubMed ID: 22843279
[TBL] [Abstract][Full Text] [Related]
2. Multiple angiogenetic factors are upregulated in POEMS syndrome.
Yamada Y; Sawai S; Misawa S; Kanai K; Shibuya K; Mori M; Moriya J; Sogawa K; Yamamoto H; Beppu M; Taniguchi J; Nakaseko C; Nomura F; Kuwabara S
Ann Hematol; 2013 Jan; 92(2):245-8. PubMed ID: 23053181
[TBL] [Abstract][Full Text] [Related]
3. Skin manifestations and vascular endothelial growth factor levels in POEMS syndrome: impact of autologous hematopoietic stem cell transplantation.
Barete S; Mouawad R; Choquet S; Viala K; Leblond V; Musset L; Amoura Z; Khayat D; Francès C
Arch Dermatol; 2010 Jun; 146(6):615-23. PubMed ID: 20566924
[TBL] [Abstract][Full Text] [Related]
4. Growth factors and proinflammatory cytokines in the renal involvement of POEMS syndrome.
Soubrier M; Sauron C; Souweine B; Larroche C; Wechsler B; Guillevin L; Piette JC; Rousset H; Deteix P
Am J Kidney Dis; 1999 Oct; 34(4):633-8. PubMed ID: 10516342
[TBL] [Abstract][Full Text] [Related]
5. Neurologic improvement after peripheral blood stem cell transplantation in POEMS syndrome.
Kuwabara S; Misawa S; Kanai K; Suzuki Y; Kikkawa Y; Sawai S; Hattori T; Nishimura M; Nakaseko C
Neurology; 2008 Nov; 71(21):1691-5. PubMed ID: 18832140
[TBL] [Abstract][Full Text] [Related]
6. [POEMS syndrome diagnosed by detection of M-protein on immunofixation and increased level of vascular endothelial growth factor].
Hattori Y; Taguchi J; Imai N; Wasano K; Matsuura S; Koharazawa H; Ishigatsubo Y; Fujisawa S
Rinsho Ketsueki; 2011 Apr; 52(4):219-22. PubMed ID: 21566409
[TBL] [Abstract][Full Text] [Related]
7. [Crow-Fukase syndrome and VEGF].
Arimura K; Hashiguchi T; Watanabe O
Brain Nerve; 2008 Jun; 60(6):611-9. PubMed ID: 18567356
[TBL] [Abstract][Full Text] [Related]
8. Early weight loss and high serum tumor necrosis factor-alpha levels in polyneuropathy, organomegaly, endocrinopathy, M protein, skin changes syndrome.
Gherardi RK; Chouaïb S; Malapert D; Bélec L; Intrator L; Degos JD
Ann Neurol; 1994 Apr; 35(4):501-5. PubMed ID: 8154881
[TBL] [Abstract][Full Text] [Related]
9. Inverse correlation between VEGF and soluble VEGF receptor 2 in POEMS with AIDP responsive to intravenous immunoglobulin.
Terracciano C; Fiore S; Doldo E; Manzari V; Marfia GA; Bernardi G; Massa R; Albonici L
Muscle Nerve; 2010 Sep; 42(3):445-8. PubMed ID: 20589895
[TBL] [Abstract][Full Text] [Related]
10. Vascular endothelial growth factor as a predictive marker for POEMS syndrome treatment response: retrospective cohort study.
Misawa S; Sato Y; Katayama K; Hanaoka H; Sawai S; Beppu M; Nomura F; Shibuya K; Sekiguchi Y; Iwai Y; Watanabe K; Amino H; Ohwada C; Takeuchi M; Sakaida E; Nakaseko C; Kuwabara S
BMJ Open; 2015 Nov; 5(11):e009157. PubMed ID: 26560063
[TBL] [Abstract][Full Text] [Related]
11. Relapse of polyneuropathy, organomegaly, endocrinopathy, M-protein, and skin changes (POEMS) syndrome without increased level of vascular endothelial growth factor following successful autologous peripheral blood stem cell transplantation.
Imai N; Taguchi J; Yagi N; Konishi T; Serizawa M; Kobari M
Neuromuscul Disord; 2009 May; 19(5):363-5. PubMed ID: 19269178
[TBL] [Abstract][Full Text] [Related]
12. Angiogenetic factors and biochemical markers of bone metabolism in POEMS syndrome treated with high-dose therapy and autologous stem cell support.
Kastritis E; Terpos E; Anagnostopoulos A; Xilouri I; Dimopoulos MA
Clin Lymphoma Myeloma; 2006 Jul; 7(1):73-6. PubMed ID: 16879774
[TBL] [Abstract][Full Text] [Related]
13. Pentraxin-3 and VEGF in POEMS syndrome: a 2-year longitudinal study.
Briani C; Dalla Torre C; Lessi F; Cavallaro T; Scarlato M; Ferrari S; Campagnolo M; Lucchetta M; Cabrini I; Morbin M; Lauria G; Adami F; Manfredi AA
J Neuroimmunol; 2014 Dec; 277(1-2):189-92. PubMed ID: 25447599
[TBL] [Abstract][Full Text] [Related]
14. Plasma-cell dyscrasia with polyneuropathy. The spectrum of POEMS syndrome.
Miralles GD; O'Fallon JR; Talley NJ
N Engl J Med; 1992 Dec; 327(27):1919-23. PubMed ID: 1333569
[TBL] [Abstract][Full Text] [Related]
15. [Two cases of POEMS syndrome with increased vascular endothelial growth factor (VEGF)].
Arimura H; Watanabe O; Arimura K; Maruyama I; Hokezu Y
Rinsho Shinkeigaku; 1997 Sep; 37(9):817-23. PubMed ID: 9430997
[TBL] [Abstract][Full Text] [Related]
16. [Pro-inflammatory cytokines: a pathogenic key of POEMS syndrome].
Gherardi RK; Authier FJ; Belec L
Rev Neurol (Paris); 1996 May; 152(5):409-12. PubMed ID: 8881441
[TBL] [Abstract][Full Text] [Related]
17. POEMS syndrome associated with ischemic stroke.
Kang K; Chu K; Kim DE; Jeong SW; Lee JW; Roh JK
Arch Neurol; 2003 May; 60(5):745-9. PubMed ID: 12756139
[TBL] [Abstract][Full Text] [Related]
18. Pachymeningeal involvement in POEMS syndrome: dramatic cerebral MRI improvement after lenalidomide therapy.
Briani C; Manara R; Lessi F; Citton V; Zambello R; Adami F
Am J Hematol; 2012 May; 87(5):539-41. PubMed ID: 22389216
[TBL] [Abstract][Full Text] [Related]
19. Low levels of interleukin-1 receptor antagonist (IL-1RA) predict engraftment syndrome after autologous stem cell transplantation in POEMS syndrome and other plasma cell neoplasms.
Keyzner A; D'Souza A; Lacy M; Gertz M; Hayman S; Buadi F; Kumar S; Dingli D; Engebretson A; Tong C; Dispenzieri A
Biol Blood Marrow Transplant; 2013 Sep; 19(9):1395-8. PubMed ID: 23792270
[TBL] [Abstract][Full Text] [Related]
20. Altered axonal excitability properties and nerve edema in POEMS syndrome.
Mitsuma S; Misawa S; Shibuya K; Isose S; Sekiguchi Y; Iwai Y; Beppu M; Watanabe K; Amino H; Kuwabara S
Clin Neurophysiol; 2015 Oct; 126(10):2014-8. PubMed ID: 25735476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
